```json
{
    "Variants Include": [
        {
            "Gene": "PARK2",
            "variants": [
                {
                    "HGVS": "NM_004562.3:c.718T>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "T",
                        "alt": "C",
                        "position": "718"
                    },
                    "Protein Change": {
                        "ref": "T",
                        "alt": "R",
                        "position": "240"
                    },
                    "Description in input context": "parkinT240R, with a Thrâ†’Arg mutation in RING1 domain"
                },
                {
                    "HGVS": "NM_004562.3:c.124G>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "G",
                        "alt": "C",
                        "position": "124"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "P",
                        "position": "42"
                    },
                    "Description in input context": "parkinR42P, with a mutation in Ubl-domain"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "311"
                    },
                    "Protein Change": {
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Description in input context": "parkinQ311stop"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Autosomal recessive juvenile parkinsonism",
        "MONDO": "MONDO:0015448"
    },
    "Experiment Method": [
        {
            "Assay Method": "Co-immunoprecipitation",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293",
                "Description": "HEK293 cells were used for co-immunoprecipitation experiments."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.718T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "parkinT240R did not associate with UbcH7."
                },
                {
                    "Variant": "NM_004562.3:c.124G>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "parkinR42P was capable of binding UbcH7."
                },
                 {
                    "Variant": "N.D.",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "N.D."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type parkin was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Lysates without Myc-parkin were used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Presence of UbcH7 co-immunoprecipitation with parkin.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Absence of UbcH7 co-immunoprecipitation with parkin.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ubiquitination Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y",
                "Description": "Human dopaminergic neuroblastoma SH-SY5Y cells were used."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.718T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "None of the mutant IP-parkins supported this in vitro ubiquitination"
                },
                {
                    "Variant": "NM_004562.3:c.124G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "None of the mutant IP-parkins supported this in vitro ubiquitination"
                },
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "None of the mutant IP-parkins supported this in vitro ubiquitination"
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "IP-Parkin(SH-SY5Y) was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "IP-Parkin (HEK293) was used as negative control"
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "High molecular ubiquitinated signals",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Absence of ubiquitinated signals.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```